ClassID:

20612

A61K35/13 - page 2 - CPC Classification

Classification description:

Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells Tumour cells, irrespective of tissue of origin

Recent Application in this class:
#301
20080075744
2008-03-27

Pharmaceutical composition for cancer treatment containing cells that express a membrane cytokine

#302
20080069802
2008-03-20

Modified virus

#303
20080057029
2008-03-06

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine

#304
20080031886
2008-02-07

Viruses for the treatment of cellular proliferative disorders

#305
20080020463
2008-01-24

Entrapped stem cells and uses thereof

#306
20080019981
2008-01-24

Viruses for the treatment of cellular proliferative disorders

#307
20080019980
2008-01-24

Viruses for the treatment of cellular proliferative disorders

#308
20080003657
2008-01-03

Recombinant rabies virus compositions

#309
20070269459
2007-11-22

Mutant G Genes of the Trout Viral Haemorrhagic Septicaemia Virus (Vhsv) and Applications Thereof

#310
20070254357
2007-11-01

Gene therapy using replication competent targeted adenoviral vectors

#311
20070212338
2007-09-13

Hybrid cells

#312
20070190029
2007-08-16

Listeria-induced immunorecruitment and activation, and methods of use thereof

#313
20070154918
2007-07-05

44 Human Secreted Proteins

#314
20070128184
2007-06-07

Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins

#315
20070122385
2007-05-31

Replication competent viruses capable of silencing virus inhibitory factor expression

#316
20070110720
2007-05-17

Vectors, mutant viruses and methods for generating mutant viruses

#317
20070099176
2007-05-03

Methods of expressing LIM mineralization protein

#318
20070098689
2007-05-03

Mutant herpes simplex viruses comprising nucleic acid encoding a nitroreductase

#319
20070098637
2007-05-03

Generation and use of vasculogenic tumors and products derived from same

#320
20070086984
2007-04-19

Viruses for the treatment of cellular proliferative disorders

#321
20070081972
2007-04-12

Polymer-based delivery system for immunotherapy of cancer

#322
20070077231
2007-04-05

Immune effector cells pre-infected with oncolytic virus

#323
20070065409
2007-03-22

Use of pleiotrophin in the diagnosis, treatment and prevention of disease

#324
20070054357
2007-03-08

Identification of useful bacteriophage

#325
20060281095
2006-12-14

44 human secreted proteins

#326
20060258006
2006-11-16

Retroviral vector

#327
20060240038
2006-10-26

Cells used as carriers for bacteria

#328
20060222632
2006-10-05

Disinfection of foodstuffs

#329
20060216278
2006-09-28

Entrapped stem cells and uses thereof

#330
20060188522
2006-08-24

Viral agents

#331
20060188479
2006-08-24

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#332
20060165668
2006-07-27

Genetically modified tumor cells as cancer vaccines

#333
20060153807
2006-07-13

Vector-mediated gene regulation in midbrain dopamine neurons

#334
20060149037
2006-07-06

Cupredoxin derived transport agents and methods of use thereof

#335
20060148073
2006-07-06

Enhancement of adenoviral oncolytic activity by modification of the E1A gene product

#336
20060127981
2006-06-15

Targeting viruses using a modified sindbis glycoprotein

#337
20060127359
2006-06-15

Methods and compositions for heat activated gene therapy using cytolethal distending toxin

#338
20060121509
2006-06-08

Generation of replication competent viruses for therapeutic use

#339
20060093590
2006-05-04

Pseudotyped retrovirus with modified ebola glycoprotein

#340
20060088869
2006-04-27

Viral purification methods

#341
20060062764
2006-03-23

Fiber-modified adenoviral vectors for enhanced transduction of tumor cells

#342
20060035371
2006-02-16

Hybrid adeno-retroviral vector for the transfection of cells

#343
20050277605
2005-12-15

Superior molecular vaccine based on self-replicating RNA, suicidal DNA or naked DNA vector, that links antigen with polypeptide that promotes antigen presentation

#344
20050260734
2005-11-24

Packaging cells

#345
20050255110
2005-11-17

Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies

#346
20050249700
2005-11-10

Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling

#347
20050226847
2005-10-13

Adeno-associated virus producer system

#348
20050201993
2005-09-15

Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase

#349
20050180951
2005-08-18

Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer

#350
20050169890
2005-08-04

Adenovirus vectors containing cell status-specific response elements and methods of use thereof

#351
20050158244
2005-07-21

Hybrid cells

#352
20050153335
2005-07-14

44 human secreted proteins

#353
20050136037
2005-06-23

Bacteriophage for lysis of and compositions and uses thereof

#354
20050079537
2005-04-14

44 human secreted proteins

#355
20050053586
2005-03-10

Entrapped stem cells and uses thereof

#356
20050009085
2005-01-13

44 Human secreted proteins

#357
20050002906
2005-01-06

Gene therapy using replication competent targeted adenoviral vectors

#358
20050002903
2005-01-06

Gene delivery system and methods of use